![Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)](https://pubs.rsc.org/image/article/2021/cs/d0cs00310g/d0cs00310g-f10_hi-res.gif)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
![Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)](https://pubs.rsc.org/image/article/2021/cs/d0cs00310g/d0cs00310g-f3_hi-res.gif)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
![The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-021-00484-2/MediaObjects/41571_2021_484_Fig1_HTML.png)
The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology
![Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)](https://pubs.rsc.org/image/article/2021/cs/d0cs00310g/d0cs00310g-f4_hi-res.gif)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
![Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-021-00470-8/MediaObjects/41571_2021_470_Fig1_HTML.png)
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
![Chromatographic evaluation of ADC aggregation and hydrophilicity. (a-f)... | Download Scientific Diagram Chromatographic evaluation of ADC aggregation and hydrophilicity. (a-f)... | Download Scientific Diagram](https://www.researchgate.net/publication/323953157/figure/fig1/AS:607172429893632@1521772596667/Chromatographic-evaluation-of-ADC-aggregation-and-hydrophilicity-a-f-Aggregation-was.png)
Chromatographic evaluation of ADC aggregation and hydrophilicity. (a-f)... | Download Scientific Diagram
![Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41571-021-00470-8/MediaObjects/41571_2021_470_Fig2_HTML.png)
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
![Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology](https://www.frontiersin.org/files/Articles/445531/fonc-09-00167-HTML/image_m/fonc-09-00167-g001.jpg)
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
![Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd.2016.268/MediaObjects/41573_2017_Article_BFnrd2016268_Fig1_HTML.jpg)
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
![Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/73d7fe02-52ae-4cd9-8727-f7d5f0e58864/jcp28967-gra-0001-m.jpg)
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library
![Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)](https://pubs.rsc.org/image/article/2021/cs/d0cs00310g/d0cs00310g-f14_hi-res.gif)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
![Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)](https://pubs.rsc.org/image/article/2021/cs/d0cs00310g/d0cs00310g-f6_hi-res.gif)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Comparison of Analytical Methods for Antibody–Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation
![Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index | Nature Biotechnology Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnbt.3212/MediaObjects/41587_2015_Article_BFnbt3212_Fig1_HTML.jpg)
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index | Nature Biotechnology
![CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001 CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001](https://pubs.rsc.org/image/chapter/bk9781788010771/bk9781788010771-00001/bk9781788010771-00001-u1_hi-res.gif)
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
![Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-017-01257-1/MediaObjects/41467_2017_1257_Fig1_HTML.jpg)